ELTX — Elicio Therapeutics Inc Com

Ownership history in MEYER HANDELMAN CO  ·  11 quarters on record

This page tracks every 13F SEC filing in which MEYER HANDELMAN CO reported a position in Elicio Therapeutics Inc Com (ELTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q2)
Avg. % of fund
0.0%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 13,899 — 0% 0.00% $111K $7.96
2025 Q3 UNCHANGED 13,899 — 0% 0.00% $152K $10.94
2025 Q2 UNCHANGED 13,899 — 0% 0.00% $107K $7.72
2025 Q1 UNCHANGED 13,899 — 0% 0.00% $86K $6.16
2024 Q4 UNCHANGED 13,899 — 0% 0.00% $71K $5.10
2024 Q3 UNCHANGED 13,899 — 0% 0.00% $70K $5.03
2024 Q2 UNCHANGED 13,899 — 0% 0.00% $57K $4.11
2024 Q1 UNCHANGED 13,899 — 0% 0.00% $106K $7.60
2023 Q4 UNCHANGED 13,899 — 0% 0.00% $116K $8.34
2023 Q3 ADDED 13,899 +661 +5.0% 0.00% $117K $8.45
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ELTX price (monthly, adj. close)

Other funds also holding ELTX

As of 2025 Q4 — sorted by position size

Knoll Capital Management, LLC 3Y 7Y 2.3% Sio Capital Management, LLC 3Y 7Y 0.37% CM Management, LLC 3Y 0.17% 683 Capital Management, LLC 3Y 7Y 0.02% Mayflower Financial Advisors, LLC 3Y 0.01% OCCUDO QUANTITATIVE STRATEGIES LP 3Y 0.01% MOODY LYNN & LIEBERSON, LLC 3Y 7Y 0.0% BALYASNY ASSET MANAGEMENT L.P. 3Y 7Y 0.0% Quadrature Capital Ltd 3Y 7Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0%
← Back to MEYER HANDELMAN CO Holdings